Study Title
HERPET: A Mechanistic Non-Invasive Imaging Study of HER2 Expression in Breast Cancer Using [18F]GE-226 Positron Emission Tomography
Study Details
Description:
This mechanistic study will be the first study to assess the efficacy of [18F]GE-226 to target HER2 expression in patients with metastatic breast cancer. The study will establish the pharmacokinetics of [18F]GE-226 and the optimum time-point for performing static scans in this patient population.
Sponsor:
Imperial College London
Contacts:
HERPET Trial Coordinatorherpet@imperial.ac.uk
Gosala Gopalakrishnan, PhDg.gopalakrishnan@imperial.ac.uk
0207 59 42804
Government Study Link:
NCT03827317 - Click here to see study onClinicalTrials.gov